Understanding how elderly patients process drug information: A test of a theory of information processing

The goal of this research was to apply a well-known model of consumer behavior, the Elaboration Likelihood Model (ELM), to "direct-to-consumer" advertising of prescription drugs aimed at elderly consumers. In particular, the specific aim was to determine whether the effect of promotional a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical research 1997-11, Vol.14 (11), p.1589-1596
Hauptverfasser: CHRISTENSEN, T. P, ASCIONE, F. J, BAGOZZI, R. P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1596
container_issue 11
container_start_page 1589
container_title Pharmaceutical research
container_volume 14
creator CHRISTENSEN, T. P
ASCIONE, F. J
BAGOZZI, R. P
description The goal of this research was to apply a well-known model of consumer behavior, the Elaboration Likelihood Model (ELM), to "direct-to-consumer" advertising of prescription drugs aimed at elderly consumers. In particular, the specific aim was to determine whether the effect of promotional aspects of consumer drug advertising predicted by the ELM could by demonstrated on elderly consumers' product attitudes and perceptions of risk. Subject reaction to a fictitious drug advertisement was assessed using a 2 x 2 x 2 factorial design based on the theoretical concepts of the ELM. the advertisement message varied in the expertise of the product endorser, the expected involvement or interest level of the study subject, and the content of the advertisement message. Analysis of variance revealed a three-way interaction effect between involvement, argument quality, and source credibility on subjects' attitudes toward the product [F(1, 123) = 4.77, p = 0.03] and perceptions of risk [F(1, 118) = 3.22, p = 0.08]. The information content of the ads had an impact on subject's attitudes under the low involvement/low credibility condition but not the low involvement/high credibility condition. Under high involvement conditions, the information content of the ad impacted attitudes under both the high and low credibility conditions. It appears that the ELM may be a useful model for determining when elderly individuals are more likely to be influenced by the information content or the promotional aspects of consumer advertisements for prescription drugs.
doi_str_mv 10.1023/A:1012182419037
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79523606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79523606</sourcerecordid><originalsourceid>FETCH-LOGICAL-p262t-b8378b868b46f1a08a25bbcbe5bf0cb9617559bdba6583c7434e166a8df1219e3</originalsourceid><addsrcrecordid>eNpdkMtLw0AQxhdRaq2ePQmLiLfovrKP3krxBQUvFryF3WTTpiSbuJsg_e_dYhTxNMN8v5n5ZgC4xOgOI0LvF3OMMMGSMKwQFUdgilNBE4XY-zGYIkFYIgXDp-AshB1CSGLFJmCiGGVEqCmo1q6wPvTaFZXbwG37CW0dK_UedrqvrOsD7Hyb2xBg4YcNrFzZ-iZKrZvDBext6GFbQg37rW39_pD_QX564-xzcFLqOtiLMc7A-vHhbfmcrF6fXpaLVdIRTvrESCqkkVwaxkuskdQkNSY3NjUlyo3iWKSpMoXRPJU0F_EQiznXsijjH5SlM3D7PTeu_hiivaypQm7rWjvbDiETKiWUIx7B63_grh28i94yQgiXCuMDdDVCg2lskXW-arTfZ-MDo34z6jrkui69dnkVfjGCpKAS0S_apoAI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222689116</pqid></control><display><type>article</type><title>Understanding how elderly patients process drug information: A test of a theory of information processing</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>CHRISTENSEN, T. P ; ASCIONE, F. J ; BAGOZZI, R. P</creator><creatorcontrib>CHRISTENSEN, T. P ; ASCIONE, F. J ; BAGOZZI, R. P</creatorcontrib><description>The goal of this research was to apply a well-known model of consumer behavior, the Elaboration Likelihood Model (ELM), to "direct-to-consumer" advertising of prescription drugs aimed at elderly consumers. In particular, the specific aim was to determine whether the effect of promotional aspects of consumer drug advertising predicted by the ELM could by demonstrated on elderly consumers' product attitudes and perceptions of risk. Subject reaction to a fictitious drug advertisement was assessed using a 2 x 2 x 2 factorial design based on the theoretical concepts of the ELM. the advertisement message varied in the expertise of the product endorser, the expected involvement or interest level of the study subject, and the content of the advertisement message. Analysis of variance revealed a three-way interaction effect between involvement, argument quality, and source credibility on subjects' attitudes toward the product [F(1, 123) = 4.77, p = 0.03] and perceptions of risk [F(1, 118) = 3.22, p = 0.08]. The information content of the ads had an impact on subject's attitudes under the low involvement/low credibility condition but not the low involvement/high credibility condition. Under high involvement conditions, the information content of the ad impacted attitudes under both the high and low credibility conditions. It appears that the ELM may be a useful model for determining when elderly individuals are more likely to be influenced by the information content or the promotional aspects of consumer advertisements for prescription drugs.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1023/A:1012182419037</identifier><identifier>PMID: 9434279</identifier><identifier>CODEN: PHREEB</identifier><language>eng</language><publisher>New York, NY: Springer</publisher><subject>Advertising as Topic ; Aged ; Aged, 80 and over ; Attitude to Health ; Biological and medical sciences ; Data Collection ; Drug Therapy - psychology ; Female ; Humans ; Male ; Medical sciences ; Mental Processes ; Middle Aged ; Prevention and actions ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Risk Factors ; Specific populations (family, woman, child, elderly...)</subject><ispartof>Pharmaceutical research, 1997-11, Vol.14 (11), p.1589-1596</ispartof><rights>1998 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Nov 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2087380$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9434279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHRISTENSEN, T. P</creatorcontrib><creatorcontrib>ASCIONE, F. J</creatorcontrib><creatorcontrib>BAGOZZI, R. P</creatorcontrib><title>Understanding how elderly patients process drug information: A test of a theory of information processing</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><description>The goal of this research was to apply a well-known model of consumer behavior, the Elaboration Likelihood Model (ELM), to "direct-to-consumer" advertising of prescription drugs aimed at elderly consumers. In particular, the specific aim was to determine whether the effect of promotional aspects of consumer drug advertising predicted by the ELM could by demonstrated on elderly consumers' product attitudes and perceptions of risk. Subject reaction to a fictitious drug advertisement was assessed using a 2 x 2 x 2 factorial design based on the theoretical concepts of the ELM. the advertisement message varied in the expertise of the product endorser, the expected involvement or interest level of the study subject, and the content of the advertisement message. Analysis of variance revealed a three-way interaction effect between involvement, argument quality, and source credibility on subjects' attitudes toward the product [F(1, 123) = 4.77, p = 0.03] and perceptions of risk [F(1, 118) = 3.22, p = 0.08]. The information content of the ads had an impact on subject's attitudes under the low involvement/low credibility condition but not the low involvement/high credibility condition. Under high involvement conditions, the information content of the ad impacted attitudes under both the high and low credibility conditions. It appears that the ELM may be a useful model for determining when elderly individuals are more likely to be influenced by the information content or the promotional aspects of consumer advertisements for prescription drugs.</description><subject>Advertising as Topic</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Attitude to Health</subject><subject>Biological and medical sciences</subject><subject>Data Collection</subject><subject>Drug Therapy - psychology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental Processes</subject><subject>Middle Aged</subject><subject>Prevention and actions</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Risk Factors</subject><subject>Specific populations (family, woman, child, elderly...)</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkMtLw0AQxhdRaq2ePQmLiLfovrKP3krxBQUvFryF3WTTpiSbuJsg_e_dYhTxNMN8v5n5ZgC4xOgOI0LvF3OMMMGSMKwQFUdgilNBE4XY-zGYIkFYIgXDp-AshB1CSGLFJmCiGGVEqCmo1q6wPvTaFZXbwG37CW0dK_UedrqvrOsD7Hyb2xBg4YcNrFzZ-iZKrZvDBext6GFbQg37rW39_pD_QX564-xzcFLqOtiLMc7A-vHhbfmcrF6fXpaLVdIRTvrESCqkkVwaxkuskdQkNSY3NjUlyo3iWKSpMoXRPJU0F_EQiznXsijjH5SlM3D7PTeu_hiivaypQm7rWjvbDiETKiWUIx7B63_grh28i94yQgiXCuMDdDVCg2lskXW-arTfZ-MDo34z6jrkui69dnkVfjGCpKAS0S_apoAI</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>CHRISTENSEN, T. P</creator><creator>ASCIONE, F. J</creator><creator>BAGOZZI, R. P</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19971101</creationdate><title>Understanding how elderly patients process drug information: A test of a theory of information processing</title><author>CHRISTENSEN, T. P ; ASCIONE, F. J ; BAGOZZI, R. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p262t-b8378b868b46f1a08a25bbcbe5bf0cb9617559bdba6583c7434e166a8df1219e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Advertising as Topic</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Attitude to Health</topic><topic>Biological and medical sciences</topic><topic>Data Collection</topic><topic>Drug Therapy - psychology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental Processes</topic><topic>Middle Aged</topic><topic>Prevention and actions</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Risk Factors</topic><topic>Specific populations (family, woman, child, elderly...)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHRISTENSEN, T. P</creatorcontrib><creatorcontrib>ASCIONE, F. J</creatorcontrib><creatorcontrib>BAGOZZI, R. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHRISTENSEN, T. P</au><au>ASCIONE, F. J</au><au>BAGOZZI, R. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Understanding how elderly patients process drug information: A test of a theory of information processing</atitle><jtitle>Pharmaceutical research</jtitle><addtitle>Pharm Res</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>14</volume><issue>11</issue><spage>1589</spage><epage>1596</epage><pages>1589-1596</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><coden>PHREEB</coden><abstract>The goal of this research was to apply a well-known model of consumer behavior, the Elaboration Likelihood Model (ELM), to "direct-to-consumer" advertising of prescription drugs aimed at elderly consumers. In particular, the specific aim was to determine whether the effect of promotional aspects of consumer drug advertising predicted by the ELM could by demonstrated on elderly consumers' product attitudes and perceptions of risk. Subject reaction to a fictitious drug advertisement was assessed using a 2 x 2 x 2 factorial design based on the theoretical concepts of the ELM. the advertisement message varied in the expertise of the product endorser, the expected involvement or interest level of the study subject, and the content of the advertisement message. Analysis of variance revealed a three-way interaction effect between involvement, argument quality, and source credibility on subjects' attitudes toward the product [F(1, 123) = 4.77, p = 0.03] and perceptions of risk [F(1, 118) = 3.22, p = 0.08]. The information content of the ads had an impact on subject's attitudes under the low involvement/low credibility condition but not the low involvement/high credibility condition. Under high involvement conditions, the information content of the ad impacted attitudes under both the high and low credibility conditions. It appears that the ELM may be a useful model for determining when elderly individuals are more likely to be influenced by the information content or the promotional aspects of consumer advertisements for prescription drugs.</abstract><cop>New York, NY</cop><pub>Springer</pub><pmid>9434279</pmid><doi>10.1023/A:1012182419037</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0724-8741
ispartof Pharmaceutical research, 1997-11, Vol.14 (11), p.1589-1596
issn 0724-8741
1573-904X
language eng
recordid cdi_proquest_miscellaneous_79523606
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Advertising as Topic
Aged
Aged, 80 and over
Attitude to Health
Biological and medical sciences
Data Collection
Drug Therapy - psychology
Female
Humans
Male
Medical sciences
Mental Processes
Middle Aged
Prevention and actions
Public health. Hygiene
Public health. Hygiene-occupational medicine
Risk Factors
Specific populations (family, woman, child, elderly...)
title Understanding how elderly patients process drug information: A test of a theory of information processing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A04%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Understanding%20how%20elderly%20patients%20process%20drug%20information:%20A%20test%20of%20a%20theory%20of%20information%20processing&rft.jtitle=Pharmaceutical%20research&rft.au=CHRISTENSEN,%20T.%20P&rft.date=1997-11-01&rft.volume=14&rft.issue=11&rft.spage=1589&rft.epage=1596&rft.pages=1589-1596&rft.issn=0724-8741&rft.eissn=1573-904X&rft.coden=PHREEB&rft_id=info:doi/10.1023/A:1012182419037&rft_dat=%3Cproquest_pubme%3E79523606%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222689116&rft_id=info:pmid/9434279&rfr_iscdi=true